Schedule 13G ownership disclosure

RedHill Biopharma Ltd.

Security class unavailable · CUSIP: M8208M118

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,540,400
Percent of class
8.4300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-23-000013
Form type
SC 13G
Filer
RedHill Biopharma Ltd.
CIK
CIK 1553846
Filed
Jan 04, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub